Current Evidence: GLP-1 Drugs and Addiction Research Potential Mechanisms Behind GLP-1 Effects on Addictive Behaviours Clinical Considerations and Limitations of Current Research What This Means for Patients: Practical Guidance Scientific References Frequently Asked Questions What Are GLP-1 Medications and How Do They Work
A 16-week phase 1 trial for the oral formulation reports a mean weight loss of 13% in the treatment group, compared to 1% for placebo (82)
Luh et al, 2017) was used to assess motor coordination
Almost a decade ago, a review of these services by the Medical Services Advisory Committee 234 MSAC is an independent scientific advisory committee that provides evidence-based advice to government to inform funding decisions about new medical services, including their safety, clinical effectiveness, and cost-effectiveness: Department of Health, Disability, and Ageing (2024d)

Hepatic synthesis of glutathione and nutritional substrates, co-factors, and other nutrients that influence metabolism 5-Methyl-tetrahydrofolate (5MTHF), system alanineserinecysteine (ASC), cystathionine--synthase (CBS), cystathionine gamma-lyase (CGL), electrophile response element (EpRE), glutathione-S-transferase (GST), glutamate cysteine ligase (GCL), glutathione reductase (GRx), glutathione peroxidase (GPx), glutathione synthetase (GSx), hydrogen peroxide (H 2 O 2 ), Nuclear factor erythroid factor-2-related factor 2 (Nrf2), S-adenosylmethionine (SAMe), S-adenosylhomocysteine (SAH), tetrahydrofolate (THF), thioredoxin reductase 1 (TRR1), water (H 2 O), cystine/glutamate antiporter system (x c )